Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 26, 2025Italian Journal of MedicineOpen Access

P93 | Hypereosinophilic syndrome and novel eosinophil-depleting therapies

View Full Paper
Ask AI
Bookmark
Share

Discussion

Loading...

Member takes

Overview

Case report shows efficacy of mepolizumab in reducing eosinophil counts in an elderly patient, suggesting a potential treatment option.

Key Points

  • Mepolizumab significantly decreased eosinophil counts and minimized steroid side effects in the patient.
  • The patient experienced symptom resolution after receiving mepolizumab, maintaining benefits over 6 months.
  • Assessment included comprehensive diagnostic tests to exclude other conditions like malignancies.
  • Targeted IL-5 therapy offers a promising long-term treatment for hypereosinophilic syndrome.

Cite This Study

A 2025 study studied this question.

synapsesocial.com/papers/68af7dfe7567bf4f94ff5657https://doi.org/10.4081/itjm.2025.2287
View Full Paper
Ask AI
Bookmark
Share